Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Pointing Out Added Value to Protect Radiologist Turf

September 1, 2011 12:41 pm | by Diagnostic Imaging | News | Comments

Radiologist groups shouldn't be shy about making clear their value to hospitals, according to an article published online today in the Journal of the American College of Radiology.

Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference

September 1, 2011 12:41 pm | by Bio-Medicine.Org | News | Comments

BATESVILLE, Ind., Sept. 1, 2011 /- Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a management presentation at the Morgan Stanley Global Healthcare Conference in New York City on September 14, 2011, at 8:35 a.m. ET. You are invited to listen to the live discussion via...

Kimberly-Clark Health Care Announces Selling Price Increase

September 1, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., Sept. 1, 2011 /- Kimberly-Clark Health Care (KCHC) announced today that it is implementing a double-digit price increase on synthetic exam gloves due to unprecedented demand for and rising costs of raw materials, particularly butadiene and acrylonitrile.   "Despite...

Advertisement

New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population

September 1, 2011 12:36 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 1, 2011 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive.  The drug was approved based on data from two clinical...

Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4

September 1, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Sept. 1, 2011 /- Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is proud to host its second annual Infusion Site Awareness Week, Aug. 29-Sept. 4, a week-long effort to highlight the importance of proper infusion...

Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment

September 1, 2011 12:31 pm | by U.S. Food & Drug Administration | News | Comments

Reclast should not be used in patients with creatinine clearance less than 35 mL/min or in patients with evidence of acute renal impairment.

Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions

September 1, 2011 12:30 pm | by U.S. Food & Drug Administration | News | Comments

Reports of hypersensitivity reactions, including anaphylaxis (a life-threatening allergic reaction), angioedema, low blood pressure, rapid heart rate, swollen tongue, difficulty breathing, wheezing, or rash.

Osseon® Announces Commercial Release of Osseoflex®SN (Steerable Needle)

September 1, 2011 10:38 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Sept. 1, 2011 /- Today, Osseon® Therapeutics, Inc. launched the Osseoflex®SN (steerable needle). Osseoflex SN is the newest in Osseon's suite of minimally invasive products for treatment of spinal compression fractures. (Photo:  ...

Advertisement

Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference

September 1, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 1, 2011 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Stifel Nicolaus 2011 Healthcare Conference in Boston.   The live presentation...

Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Floridians are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors throughout the "Sunshine State" and for the rare, genetic diseases treated with the therapies that are made...

Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Californians are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors throughout the "Golden State" and for the rare, genetic diseases treated with the therapies that are made...

Californians and Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Florida and California are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors and for the rare, genetic diseases treated with the therapies that are made possible through plasma...

diaDexus to Present at the RW Baird 2011 Health Care Conference

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans...

Advertisement

New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

LAKE SUCCESS, N.Y., Sept. 1, 2011 /- Polar ( www.polarusa.com ), the leader in heart rate monitoring and fitness assessment technologies, today introduced the Polar Move . The new heart rate monitor is designed specifically around the needs of the education market. Its introduction...

Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin

September 1, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn., Sept. 1, 2011 /- People seeking support for healthy good cholesterol from a "flush-free" niacin supplement, prepare to be disappointed – and to make a return trip to your local pharmacy. According to leading cardiologist, Dr. Carl Lavie, medical director of...

Isis Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011

September 1, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 1, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' Healthcare Conference 2011 on Thursday, September 08, 2011 at 2:05 p.m. ET at the Four...

Volcano Corporation Announces Presentations at Upcoming Investor Conferences

September 1, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 1, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating...

Concord Medical Services Announces the Appointment of Mr. Adam Sun as Acting Chief Financial Officer

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

BEIJING, Aug. 31, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company", NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the Company has appointed...

Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 31, 2011 /- This evening, Novo Nordisk awarded sponsorships totaling $100,000 to 4 Minneapolis-based community organizations to support programs that educate people living with type 2 diabetes on how to better manage their diabetes and reduce the risk of long-term...

Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa. and LYNBROOK, N.Y., Aug. 31, 2011 /- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, and BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical company, today announced that they have dismissed all pending litigation...

Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Aug. 31, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and...

Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovoâ„¢

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, Aug. 31, 2011 /PRNewswire-Asia/ -- Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo™. This Phase 2b trial is evaluating the efficacy,...

ZINO Society, ZZIF Companies Announced

September 1, 2011 12:38 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Aug. 31, 2011 /- ZINO Society's 6th Annual ZINO Zillionaire Investment Forum (ZZIF) , September 13, 2011, 8am-4pm at the Museum of History & Industry, Seattle. ZINO Zillionaire Investment Forum will showcase 35+ entrepreneurs from seed, early-stage and expansion...

Millstone Medical Outsourcing Hires Seasoned VP of Operations to Run Memphis Facility

August 31, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FALL RIVER, Mass., Aug. 31, 2011 /- Millstone Medical Outsourcing announced today that the company hired Karl Neuberger as Vice President of Operations of the Memphis, TN, facility.  Mr. Neuberger, a highly experienced manufacturing executive, will have overall responsibility for...

Cantel Medical Corp. to Present at the CL King 9th Annual Best Ideas Conference

August 31, 2011 11:43 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Aug. 31, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the CL King 9th Annual Best Ideas Conference. The formal presentation is scheduled for 11:15 AM EDT on Tuesday, September 13, 2011...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading